V-BIO VENTURES
V-Bio Ventures is an independent venture capital firm specialized in building and financing young, innovative life science companies. The fund invests throughout Europe in start-up and early-stage companies with high growth potential focusing on technologies that provide transformational improvements in the biotech, pharmaceutical and agricultural sectors.
V-BIO VENTURES
Social Links:
Industry:
Biotechnology
Founded:
2015-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Google Maps LetsEncrypt Amazon SSL By Default HSTS Microsoft Exchange Online Office 365 Mail
Similar Organizations
Atlas Venture
Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.
Integral Molecular
Integral Molecular is a research-driven biotechnology company creating innovative technologies and a pipeline of therapeutic antibodies
Longevica
Longevica is a science-driven company with a mission to find mechanisms of life extension.
Nivalis Therapeutics
Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.
T3 Pharmaceuticals
T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-06-26 | Augustine Therapeutics | V-Bio Ventures investment in Series A - Augustine Therapeutics | 17 M EUR |
| 2024-04-24 | Flindr Therapeutics | V-Bio Ventures investment in Series A - Flindr Therapeutics | 20 M EUR |
| 2024-01-23 | Protealis | V-Bio Ventures investment in Series B - Protealis | 22 M EUR |
| 2023-09-07 | Corteria Pharmaceuticals | V-Bio Ventures investment in Series A - Corteria Pharmaceuticals | 65 M EUR |
| 2023-05-15 | Dualyx | V-Bio Ventures investment in Series A - Dualyx | 40 M EUR |
| 2022-10-04 | Sibylla Biotech | V-Bio Ventures investment in Series A - Sibylla Biotech | 23 M EUR |
| 2022-08-25 | AstriVax | V-Bio Ventures investment in Seed Round - AstriVax | 30 M EUR |
| 2022-03-16 | Precirix | V-Bio Ventures investment in Series B - Precirix | 80 M EUR |
| 2021-12-09 | Corteria Pharmaceuticals | V-Bio Ventures investment in Seed Round - Corteria Pharmaceuticals | 12 M EUR |
| 2021-07-21 | Coave Therapeutics | V-Bio Ventures investment in Series B - Coave Therapeutics | 33 M EUR |
More informations about "V-Bio Ventures"
V-Bio Ventures - Capital for Life Sciences
We are a life sciences Venture Capital fund that helps transform scientific innovation into products that positively impact people’s lives. Our extensive network and expertise in the sector allow …See details»
V-Bio Ventures - Crunchbase Investor Profile
V-Bio Ventures finds, builds and finances young, innovative companies with ambitions in the life sciences arena. V-Bio Ventures invests in seed to early-stage biotechnology, healthcare, and therapeutics companies, focusing on Europe, …See details»
V-Bio Ventures - Team
V-Bio Ventures’ team consists of investment professionals with diverse and complementary backgrounds, all sharing the same passion to build life sciences companies leveraging …See details»
V-Bio Ventures Investor Profile: Portfolio & Exits - PitchBook
Jan 8, 2024 · Founded in 2015, V-Bio Ventures is a venture capital firm based in Ghent, Belgium. The firm seeks to invest in the therapeutics, diagnostic therapies, and sustainable agriculture …See details»
V-Bio Ventures - LinkedIn
V-Bio Ventures is a venture capital fund that finds, builds and finances young, innovative companies in the life sciences arena. Our fund works closely with Belgium-based VIB, one of the...See details»
V-Bio Ventures | flanders.bio
Nov 18, 2020 · V-Bio Ventures finds, builds and finances young, innovative companies with ambitions in the life sciences arena.Our fund, established in 2015, works closely with Belgium-based VIB, one of the world’s premier life …See details»
V-Bio Ventures - Funding, Financials, Valuation & Investors
V-Bio Ventures finds, builds and finances young, innovative companies with ambitions in the life sciences arena.See details»
V-Bio Ventures: a fresh fund with a difference - BioVox
Feb 24, 2021 · As a VC fund with a focus on early-stage life sciences companies, V-Bio will be using Fund 2 to continue supporting European start-ups working on effective healthcare or sustainable agriculture solutions.See details»
V-Bio Ventures launches its second fund at €78 million - EIF
Feb 4, 2021 · V-Bio Ventures (V-Bio) announces today the first closing of V-Bio Fund 2 with capital commitments of €78 million (USD 95 million). V-Bio Ventures will continue its …See details»
V-Bio Ventures - About
We are a life sciences Venture Capital fund that helps transform scientific innovation into products that positively impact people’s lives. Our extensive network and expertise in the sector allow …See details»
V-Bio Ventures launches its second fund at EUR 78 million
Ghent, Belgium, 4 February 2021 – V-Bio Ventures (V-Bio) announces today the first closing of V-Bio Fund 2 with capital commitments of EUR 78 million (USD 95 million). V-Bio Ventures will …See details»
V-Bio Ventures - Portfolio
V-Bio Ventures cooperates with founders, innovators and entrepreneurs to establish the starting point for future success. V-Bio Ventures has been the co-creator or first lead investor of …See details»
V-Bio Ventures Fund I: Performance - PitchBook
Dec 1, 2016 · V-Bio Ventures Fund I is a venture capital fund managed by V-Bio Ventures. The fund is located in Gent, Belgium and invests in Europe. The fund targets life science, …See details»
V-Bio Ventures raises additional capital to support young biotech ...
Ghent, Belgium, 27 January 2022 – V-Bio Ventures, a venture capital company that focuses specifically on the segment of young pioneering biotech companies, has increased the capital …See details»
V-Bio Ventures: Serene new office for life sciences VC fund
Through mentoring and access to high-tech facilities, V-Bio helps startups take root and grow in a flourishing life sciences ecosystem. The collaborative and open workspace reflects its strong …See details»
V-Bio Ventures raises additional capital - flanders.bio
V-Bio Ventures, a venture capital company that focuses specifically on the segment of young pioneering biotech companies, has increased the capital of its second fund V-Bio Fund 2 to 96 …See details»
V-Bio Ventures announces final closing of its second fund
Mar 31, 2022 · V-Bio Ventures is a venture capital company that focuses specifically on the segment of young pioneering biotech companies and its strategy to invest in transformational …See details»
V-Bio Ventures - Christina Takke
Christina Takke co-founded V-Bio Ventures in 2015 and has since been a Managing Partner of the firm. Before launching V-Bio Ventures, Christina spent over 15 years in European Venture …See details»
V-Bio Ventures - Johan Cardoen
Johan Cardoen is member of the strategic advisory board of V-Bio Ventures. Until 2020 Johan was Managing Director of VIB, one of Europe’s premier life science research organizations. In …See details»
V-Bio Ventures - Contacts, Employees, Board Members
V-Bio Ventures finds, builds and finances young, innovative companies with ambitions in the life sciences arena.See details»